Following a reduction of serum calcium levels by cinacalcet, secondary hyperparathyroidism in our patient became more apparent, as her corrected serum calcium levels dropped below the reference range, with high phosphorus and persistently elevated PTH levels. The gene discussed is PTH; the disease is secondary hyperparathyroidism.